1 (R)-alpha-methylhistamine, a selective agonist of histamine H-3 receptors, promotes mucus secretion and increases the number and volume of mucus-secreting cells. The hypothesis that the increased number of mucous cells could reside in an alteration of homeostasis in the gastric epithelium was investigated. 2 (R)-alpha-methylhistamine was administered to rats 1 h (10-100 mg kg(-1) by intragastric and by intraperitoneal route) and 24 h (100 mg kg(-1) by intragastric route) prior to killing. The (S)-isomer of a-methylhistamine (55.4 mg kg(-1)), 100 times less potent than the (R)-isomer at H3 receptors, and the H-3-receptor agonist FUB 407 (9.14-91.35 mg kg(-1)) were intragrastically administered 1 h prior killing. The HI-receptor antagonist mepyramine (30 mg kg(-1)), the H-2-receptor antagonist famotidine (3 mg kg(-1)), and the H-3-receptor antagonists ciproxifan (3 mg kg(-1)) and clobenpropit (30 mg kg(-1)) were intragastrically administered 30 min before (R)-alpha-methylhistamine. Gastric tissue was processed for histology and immunohistochemistry. 3 Within 1 h, (R)-alpha-methylhistamine and FUB 407 dose-dependently increased the number of BrdU-positive cells and of apoptotic cells. (S)-alpha-methylhistamine failed to modify proliferation and apoptosis. The increase in proliferation by (R)-alpha-methylhistamine was reversed by ciproxifan and clobenpropit, but not by mepyramine and famotidine. 4 (R)-alpha-methylhistamine accelerated the differentiation towards pit cells and their outward migration 24 h after its administration. These effects were counteracted by ciproxifan. The apoptosis rate was unaffected at 24 h. 5 These findings reveal a primary role of histamine H-3-receptor ligands in modulating cell proliferation and migration in rat fundic mucosa.

Ligands for histamine H3 receptors modulate cell proliferation and migration in rat oxyntic mucosa / Morini, Giuseppina; Grandi, Daniela; Schunack, W.. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - 137:(2002), pp. 237-244. [10.1038/sj.bjp.0704853]

Ligands for histamine H3 receptors modulate cell proliferation and migration in rat oxyntic mucosa

MORINI, Giuseppina;GRANDI, Daniela;
2002

Abstract

1 (R)-alpha-methylhistamine, a selective agonist of histamine H-3 receptors, promotes mucus secretion and increases the number and volume of mucus-secreting cells. The hypothesis that the increased number of mucous cells could reside in an alteration of homeostasis in the gastric epithelium was investigated. 2 (R)-alpha-methylhistamine was administered to rats 1 h (10-100 mg kg(-1) by intragastric and by intraperitoneal route) and 24 h (100 mg kg(-1) by intragastric route) prior to killing. The (S)-isomer of a-methylhistamine (55.4 mg kg(-1)), 100 times less potent than the (R)-isomer at H3 receptors, and the H-3-receptor agonist FUB 407 (9.14-91.35 mg kg(-1)) were intragrastically administered 1 h prior killing. The HI-receptor antagonist mepyramine (30 mg kg(-1)), the H-2-receptor antagonist famotidine (3 mg kg(-1)), and the H-3-receptor antagonists ciproxifan (3 mg kg(-1)) and clobenpropit (30 mg kg(-1)) were intragastrically administered 30 min before (R)-alpha-methylhistamine. Gastric tissue was processed for histology and immunohistochemistry. 3 Within 1 h, (R)-alpha-methylhistamine and FUB 407 dose-dependently increased the number of BrdU-positive cells and of apoptotic cells. (S)-alpha-methylhistamine failed to modify proliferation and apoptosis. The increase in proliferation by (R)-alpha-methylhistamine was reversed by ciproxifan and clobenpropit, but not by mepyramine and famotidine. 4 (R)-alpha-methylhistamine accelerated the differentiation towards pit cells and their outward migration 24 h after its administration. These effects were counteracted by ciproxifan. The apoptosis rate was unaffected at 24 h. 5 These findings reveal a primary role of histamine H-3-receptor ligands in modulating cell proliferation and migration in rat fundic mucosa.
Ligands for histamine H3 receptors modulate cell proliferation and migration in rat oxyntic mucosa / Morini, Giuseppina; Grandi, Daniela; Schunack, W.. - In: BRITISH JOURNAL OF PHARMACOLOGY. - ISSN 0007-1188. - 137:(2002), pp. 237-244. [10.1038/sj.bjp.0704853]
File in questo prodotto:
File Dimensione Formato  
BJPharm2002.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 265.01 kB
Formato Adobe PDF
265.01 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1454810
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 16
social impact